NEW YORK (GenomeWeb News) – Agilent Technologies said this week that it has appointed Ron Nersesian to be company president as well as chief operating officer, effective immediately.

Nersesian has been executive vice president and COO of Agilent since November 2011. In his new post, he will continue to be responsible for Agilent's Chemical Analysis, Life Sciences, Electronic Measurement, and Order Fulfillment businesses.


Definiens has named Gerald Möller to be chairman of the company's supervisory board.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.